These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27589926)

  • 1. Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies-three-year observational study.
    Matsushita I; Motomura H; Seki E; Kimura T
    Mod Rheumatol; 2017 Jul; 27(4):570-575. PubMed ID: 27589926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies.
    Seki E; Matsushita I; Sugiyama E; Taki H; Shinoda K; Hounoki H; Motomura H; Kimura T
    Clin Rheumatol; 2009 Apr; 28(4):453-60. PubMed ID: 19104753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-up.
    Nakajima A; Terayama K; Sonobe M; Aoki Y; Takahashi H; Akatsu Y; Taniguchi S; Yamada M; Kubota A; Nakagawa K
    Mod Rheumatol; 2019 Nov; 29(6):903-909. PubMed ID: 30285585
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural joint damage and hand bone loss in patients with rheumatoid arthritis.
    Ørnbjerg LM
    Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis.
    Güler-Yüksel M; Allaart CF; Watt I; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Schaardenburg D; van Krugten MV; Dijkmans BA; Huizinga TW; Lems WF; Kloppenburg M
    Osteoarthritis Cartilage; 2010 Oct; 18(10):1256-62. PubMed ID: 20691795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
    Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α.
    Raffeiner B; Grisan E; Botsios C; Stramare R; Rizzo G; Bernardi L; Punzi L; Ometto F; Doria A
    Rheumatology (Oxford); 2017 Aug; 56(8):1320-1325. PubMed ID: 28431141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
    N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents.
    Halvorsen EH; Haavardsholm EA; Pollmann S; Boonen A; van der Heijde D; Kvien TK; Molberg Ø
    Ann Rheum Dis; 2009 Feb; 68(2):249-52. PubMed ID: 18723564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugs.
    Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Terayama K; Nakagawa K
    Mod Rheumatol; 2016 Jul; 26(4):517-21. PubMed ID: 26473376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.
    Ziegelasch M; Forslind K; Skogh T; Riklund K; Kastbom A; Berglin E
    Arthritis Res Ther; 2017 Sep; 19(1):195. PubMed ID: 28865482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.
    Naredo E; Möller I; Cruz A; Carmona L; Garrido J
    Arthritis Rheum; 2008 Aug; 58(8):2248-56. PubMed ID: 18668537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry.
    Ornbjerg LM; Ostergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Ringsdal VS; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Dencker D; Hansen A; Andersen AR; Hetland ML
    Ann Rheum Dis; 2013 Jan; 72(1):57-63. PubMed ID: 22532636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis.
    Nakajima A; Aoki Y; Terayama K; Sonobe M; Takahashi H; Saito M; Nakagawa K
    Mod Rheumatol; 2017 Nov; 27(6):967-972. PubMed ID: 28271947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.
    Loef M; Kroon FPB; Bergstra SA; van der Pol JA; Lems WF; Kerstens PJSM; Allaart CF; Kloppenburg M
    Rheumatology (Oxford); 2018 Nov; 57(11):1917-1924. PubMed ID: 29471377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Gladman DD
    Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern treatment strategies in rheumatoid arthritis.
    Hetland ML
    Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.